Latest filing published 06 Nov 2026 for 에이비엘바이오.
Filing timeline
BuySaleInsider track record
No signal scores available.
Leesanghoon: trading record in brief
Leesanghoon is a declared insider of 에이비엘바이오 (chief executive), with filings sourced from DART (FSS). Over a trading history stretching from 15 February 2021 to 6 November 2026, the count stands at 50 filings.
Every open-market trade on record is a sale: 35 sales. The totals exclude 35 filings filed without an amount.
The newest entry dates from 6 November 2026: a transaction, in 에이비엘바이오. The median gap between a trade and its publication by DART (FSS) is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leesanghoon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0DART
- 0DART
- 0DART
- 0DART
- 0KRXDART:20260403003473
- 687,000 sharesKRXDART:20251205000487
- 173,533 sharesKRXDART:20250404004101
- 35,000 sharesShareKRXDART:20250207000891
- 10,679 sharesKRXDART:20250103000564
- 21,000 sharesKRXDART:20241008000559
- 8,000 sharesKRXDART:20240830002194
- 0KRXDART:20240705000157
- 8,000 sharesKRXDART:20240701000228
- 382,737 sharesKRXDART:20240405003343
- 9,633 sharesKRXDART:20240405003288
- 8,000 sharesKRXDART:20231006000533
- 8,000 sharesKRXDART:20230818000433
- 8,000 sharesKRXDART:20230707000583
25 of 50 declarations
